Gastrointestinal Cancer

2:43
Current trials in colorectal cancer investigating panitumumab
Hani Babiker
1:20
A promising future for drug development in gastrointestinal cancer
Hani Babiker
1:43
Cemiplimab prospects: CRC, CSCC & HNSCC
Hani Babiker
3:40
The gut microbiome: role in causing and detecting colorectal cancer
Paul O'Toole
2:25
Current therapies for advanced HCC and their limitations
Michael Pishvaian
1:48
Upcoming IO combinations for advanced HCC
Michael Pishvaian
2:40
Key outcomes of the Phase 1b of atezolizumab and bevacizumab for advanced HCC
Michael Pishvaian
3:40
Moving beyond monotherapy in HCC
Arndt Vogel
2:04
Synergy of anti-androgenic agents and immune checkpoint inhibitors in HCC
Michel Ducreux
2:31
Treatment landscape for HCC
Arndt Vogel
1:23
Future therapeutic strategies for HCC
Arndt Vogel
1:54
PD-L1 and other biomarkers for renal cell carcinoma
Hans Hammers
1:45
Immuno-oncology in renal cell carcinoma: new combinations are coming
Hans Hammers
1:49
HCC clinical trial data from ESMO 2018
R. Kate Kelley
1:38
CELESTIAL trial: assessing outcomes by AFP levels in HCC
R. Kate Kelley
2:40
Immunotherapy in common solid tumors: an overview
Elaine Vickers
The content of VJOncology is intended for healthcare professionals